Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-26 10:01 am Purchase |
2024-08-19 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 149,371 10.090% |
96,300 (+181.46%) |
Filing History |
| 2024-07-01 06:47 am Sale |
2024-06-21 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 53,071 3.580% |
-96,300 (-64.47%) |
Filing History |
| 2024-05-10 2:14 pm Sale |
2024-04-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
0 0.000% |
-7,505,539 (Position Closed) |
Filing History |
| 2024-02-14 4:03 pm Sale |
2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management, LLC | 70,000 4.700% |
-33,833 (-32.58%) |
Filing History |
| 2024-02-14 10:55 am Purchase |
2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
7,505,539 16.910% |
7,237,908 (+2704.44%) |
Filing History |
| 2023-12-04 06:01 am Sale |
2023-11-14 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 149,371 10.090% |
-33 (-0.02%) |
Filing History |
| 2023-11-24 06:01 am Unchanged |
2023-11-14 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 149,404 10.090% |
0 (Unchanged) |
Filing History |
| 2023-11-02 9:54 pm Purchase |
2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 179,174 12.130% |
9,275 (+5.46%) |
Filing History |
| 2023-10-20 4:29 pm Purchase |
2023-10-18 | 13D | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 169,900 11.510% |
9,102 (+5.66%) |
Filing History |
| 2023-09-28 4:54 pm Purchase |
2023-09-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 160,798 10.900% |
81,059 (+101.66%) |
Filing History |
| 2023-08-15 06:00 am Purchase |
2023-08-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Propel Bio Management LLC | 79,739 5.400% |
79,739 (New Position) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BLACKROCK INC BLK |
31,238 2.100% |
-63,952 (-67.18%) |
Filing History |
| 2023-04-18 09:59 am Purchase |
2023-04-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 149,404 10.150% |
58,971 (+65.21%) |
Filing History |
| 2023-04-10 1:37 pm Purchase |
2023-02-28 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
267,631 18.220% |
86,139 (+47.46%) |
Filing History |
| 2023-02-14 2:23 pm Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
683 Capital Management, LLC | 103,833 7.100% |
-6,167 (-5.61%) |
Filing History |
| 2023-02-09 10:57 am Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-93,333 (Position Closed) |
Filing History |
| 2023-02-06 3:34 pm Purchase |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
BLACKROCK INC BLK |
95,190 6.500% |
12,758 (+15.48%) |
Filing History |
| 2023-02-02 2:25 pm Purchase |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
Moshe Arkin | 90,433 6.160% |
29,559 (+48.56%) |
Filing History |
| 2023-01-10 12:12 pm Sale |
2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
181,492 12.350% |
-71,512 (-28.27%) |
Filing History |
| 2022-05-11 3:01 pm Purchase |
2022-05-06 | 13G | Eiger BioPharmaceuticals, Inc. EIGR |
AMERIPRISE FINANCIAL INC AMP |
253,004 17.560% |
18,043 (+7.68%) |
Filing History |